Combination therapy with All-trans Retinoic Acid (ATRA) and Ursodeoxycholic acid (UDCA) in Primary Sclerosing Cholangitis (PSC) Human Pilot Study

Conditions

What is the purpose of this trial?

To conduct a feasibility pilot study to determine the efficacy and safety of ATRA in combination with UDCA in patients with PSC.

Participation Guidelines

Age:
Gender:

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University School of Medicine
Dates:
04/28/2011
Last Updated:
Study HIC#:
1012007734